Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia: Efficacy, safety and neurophysiological alterations under therapy – a prospective, controlled trial BoTN: Onabotulinumtoxin A zur Behandlung der Trigeminusneuralgie: Wirksamkeit, Sicherheit und neurophysiologische Veränderungen unter Therapie - eine prospektive, kontrollierte klinische Studie

Next Previous
Trial Profile

BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia: Efficacy, safety and neurophysiological alterations under therapy – a prospective, controlled trial BoTN: Onabotulinumtoxin A zur Behandlung der Trigeminusneuralgie: Wirksamkeit, Sicherheit und neurophysiologische Veränderungen unter Therapie - eine prospektive, kontrollierte klinische Studie

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Trigeminal neuralgia
  • Focus Therapeutic Use
  • Acronyms BoTN-Study
  • Sponsors Allergan

    • Most Recent Events

    • 07 Sep 2014 Planned End Date changed to 26 Aug 2016.
    • 07 Sep 2014 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top